Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Christi Deaton, Florence Nightingale Foundation Professor of Clinical Nursing Research at the University of Cambridge, will lead a new programme of research to improve the care of patients with a common form of heart failure called Heart Failure with Preserved Ejection Fraction (HFpEF).

Among other projects receiving funding under the School's Funding Round 14, Professor Deaton was awarded a grant of £633,846 for the research: “Optimising Management of Patients with Heart Failure with Preserved Ejection Fraction in Primary Care”. Read more about the research on the University of Cambridge website.

This is a tremendous opportunity to improve the care of a vulnerable group for whom there is little evidence for management.  About 50% of patients with heart failure have a preserved ejection fraction, and they are typically older with multiple comorbid conditions.  Management of comorbidities is thought to be key to managing HFpEF, as these proinflammatory conditions drive the development and progression of HFpEF.  However we also need to consider the burden of treatment that this imposes on patients who may have advanced age and frailty.”
- Prof Christi Deaton